Cutaneous Oncology, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 38-5 - September 5, 2024
- Latest edition
- Editor: David E. Fisher
- Language: English
In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide infor… Read more
Purchase options
Description
Description
In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide information on skin structure, function, and immunology, then offer overviews of the therapeutic state of the art for both melanoma and non-melanoma skin cancers. Discussions focus on unique clinical challenges and biological breakthroughs which have come to light in recent studies of cutaneous malignancies.
Key features
Key features
- Contains 16 relevant, practice-oriented topics including high risk non-melanoma skin cancers; progress in immune checkpoints for melanoma therapy; targeted therapy innovations for melanoma; advances in vaccines for melanoma; microbiome and immunotherapy; Merkel cell carcinoma; and more
- Provides in-depth clinical reviews on cutaneous oncology, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Readership
Readership
Oncology, hematology
Table of contents
Table of contents
1. Epidemiology and Screening for Melanoma
2. Cutaneous Imaging Techniques
3. Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution
4. Nevi and Melanoma
5. Advances in Adjuvant and Neoadjuvant Therapy for Melanoma
6. Targeted Therapy Innovations for Melanoma
7. Progress in Immune Checkpoint Inhibitor for Melanoma Therapy
8. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
9. Melanoma Brain Metastasis: Biology and Therapeutic Advances
10. Advances in Vaccines for Melanoma
11. Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application?
12. High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances
13. Cutaneous T-cell Lymphoma
14. Cutaneous B-Cell Lymphomas
15. Merkel Cell Carcinoma
2. Cutaneous Imaging Techniques
3. Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution
4. Nevi and Melanoma
5. Advances in Adjuvant and Neoadjuvant Therapy for Melanoma
6. Targeted Therapy Innovations for Melanoma
7. Progress in Immune Checkpoint Inhibitor for Melanoma Therapy
8. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
9. Melanoma Brain Metastasis: Biology and Therapeutic Advances
10. Advances in Vaccines for Melanoma
11. Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application?
12. High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances
13. Cutaneous T-cell Lymphoma
14. Cutaneous B-Cell Lymphomas
15. Merkel Cell Carcinoma
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 38-5
- Published: September 5, 2024
- Language: English
About the editor
About the editor
DF
David E. Fisher
Affiliations and expertise
Edward Wigglesworth Professor and Chairman, Department of Dermatology, Massachusetts General Hospital, Boston, USA; Director, Melanoma Program, MGH Cancer Center; Director, Cutaneous Biology Research Center, Harvard Medical School, Boston, USA